Continuous infusion of macrophage inflammatory protein MIP-1alpha enhances leucocyte recovery and haemopoietic progenitor cell mobilization after cyclophosphamide.

PubWeight™: 0.76‹?›

🔗 View Article (PMC 2223621)

Published in Br J Cancer on January 01, 1997

Authors

E Marshall1, L B Woolford, B I Lord

Author Affiliations

1: CRC Department of Medical Oncology, Christie Hospital, Manchester, UK.

Articles cited by this

Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu Rev Immunol (1991) 10.58

Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties. J Exp Med (1988) 5.16

Macrophage inflammatory proteins 1 and 2: members of a novel superfamily of cytokines. FASEB J (1989) 3.67

Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes. J Exp Med (1993) 3.64

Identification and characterization of an inhibitor of haemopoietic stem cell proliferation. Nature (1990) 3.29

RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes. J Exp Med (1992) 3.25

Interleukin-8 induces rapid mobilization of hematopoietic stem cells with radioprotective capacity and long-term myelolymphoid repopulating ability. Blood (1995) 1.62

Inhibitor of stem cell proliferation in normal bone marrow. Br J Haematol (1976) 1.50

Neutrophil chemotactic factors promote leukocytosis. A common mechanism for cellular recruitment from bone marrow. J Immunol (1992) 1.36

Human recombinant macrophage inflammatory protein-1 alpha and -beta and monocyte chemotactic and activating factor utilize common and unique receptors on human monocytes. J Immunol (1993) 1.29

Demonstration of stem cell inhibition and myeloprotective effects of SCI/rhMIP1 alpha in vivo. Blood (1992) 1.27

Macrophage-inflammatory protein protects multipotent hematopoietic cells from the cytotoxic effects of hydroxyurea in vivo. Blood (1992) 1.23

Mobilization of early hematopoietic progenitor cells with BB-10010: a genetically engineered variant of human macrophage inflammatory protein-1 alpha. Blood (1995) 1.02

BB-10010: an active variant of human macrophage inflammatory protein-1 alpha with improved pharmaceutical properties. Blood (1995) 1.01

Distinct and overlapping direct effects of macrophage inflammatory protein-1 alpha and transforming growth factor beta on hematopoietic progenitor/stem cell growth. Blood (1994) 0.90

Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization. J Clin Oncol (1995) 0.86

A cellular analysis of long-term haematopoietic damage in mice after repeated treatment with cyclophosphamide. Cancer Chemother Pharmacol (1986) 0.85

BB-10010/MIP-1 alpha in vivo maintains haemopoietic recovery following repeated cycles of sublethal irradiation. Br J Cancer (1996) 0.84

MIP-1 alpha increases the self-renewal capacity of the hemopoietic spleen-colony-forming cells following hydroxyurea treatment in vivo. Growth Factors (1995) 0.83

Articles by these authors

The relative spatial distributions of CFUs and CFUc in the normal mouse femur. Blood (1975) 1.77

Identification of amino acid residues critical for aggregation of human CC chemokines macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES. Characterization of active disaggregated chemokine variants. J Biol Chem (1999) 1.62

Inhibitor of stem cell proliferation in normal bone marrow. Br J Haematol (1976) 1.50

Tumour induction by methyl-nitroso-urea following preconceptional paternal contamination with plutonium-239. Br J Cancer (1998) 1.50

CD34+AC133+ cells isolated from cord blood are highly enriched in long-term culture-initiating cells, NOD/SCID-repopulating cells and dendritic cell progenitors. Stem Cells (1998) 1.40

A stimulator of stem cell proliferation in regenerating bone marrow. Biomedicine (1977) 1.38

Isolation of haemopoietic spleen colony forming cells. Lymphokine Res (1986) 1.33

Transplantation potential of peripheral blood stem cells induced by granulocyte colony-stimulating factor. Blood (1990) 1.30

Inhibitors of haemopoietic cell proliferation? Specificity of action within the haemopoietic system. Br J Cancer (1974) 1.30

The regulation of hemopoiesis in long-term bone marrow cultures. II. Stimulation and inhibition of stem cell proliferation. Blood (1980) 1.25

Stimulation of differentiation and proliferation of haemopoietic cells in vitro. J Cell Physiol (1973) 1.14

Stimulation and inhibition of proliferation in the small intestinal crypts of the mouse after in vivo administration of growth factors. Gut (1995) 1.13

Kinetics of neutrophil production in normal and neutropenic animals during the response to filgrastim (r-metHu G-CSF) or filgrastim SD/01 (PEG-r-metHu G-CSF). Clin Cancer Res (2001) 1.09

Haemopoietic stem cells and the problem of self-renewal. Blood Cells (1984) 1.06

Defective ability to self-renew in vitro of highly purified primitive haematopoietic cells. Nature (1985) 1.04

Metabolically inactive 3T3 cells can substitute for marrow stromal cells to promote the proliferation and development of multipotent haemopoietic stem cells. J Cell Physiol (1987) 1.02

Mobilization of early hematopoietic progenitor cells with BB-10010: a genetically engineered variant of human macrophage inflammatory protein-1 alpha. Blood (1995) 1.02

Identification of a common signal associated with cellular proliferation stimulated by four haemopoietic growth factors in a highly enriched population of granulocyte/macrophage colony-forming cells. EMBO J (1989) 1.02

BB-10010: an active variant of human macrophage inflammatory protein-1 alpha with improved pharmaceutical properties. Blood (1995) 1.01

A technique for the morphological examination of hemopoietic cells grown in agar. Blood (1970) 1.00

Self-maintenance capacity of CFU-S. J Cell Physiol (1980) 0.96

The distribution of haemopoietic colony-forming units in the mouse femur, and its modification by x rays. Br J Radiol (1972) 0.94

Purification of haemopoietic stem cells--the end of the road? Immunol Today (1988) 0.92

The development of spatial distributions of CFU-S and in-vitro CFC in femora of mice of different ages. Br J Haematol (1989) 0.91

The kinetic response of haemopoietic precursor cells, in vivo, to highly purified, recombinant interleukin-3. Lymphokine Res (1986) 0.91

Biological and structural properties of MIP-1 alpha expressed in yeast. Cytokine (1992) 0.91

The relationship between spleen colony production and spleen cellularity. Cell Tissue Kinet (1971) 0.89

Proliferation regulators in haemopoiesis. Clin Haematol (1979) 0.89

Myeloid cell kinetics in response to haemopoietic growth factors. Baillieres Clin Haematol (1992) 0.88

The cellular specificity of haemopoietic stem cell proliferation regulators. Br J Cancer (1984) 0.88

Stimulation of haemopoietic stem cell proliferation: characteristics of the stimulator-producing cells. Leuk Res (1982) 0.87

Measurement of the kinetic status of bone marrow precursor cells: three cautionary tales. Cell Tissue Kinet (1974) 0.87

Specific inhibition of haemopoietic stem cell proliferation: characteristics of the inhibitor producing cells. Leuk Res (1980) 0.87

Regulation of CFU-S proliferation by locally produced endogenous factors. Biomedicine (1977) 0.87

Interaction of inhibitor and stimulator in the regulation of CFU-S proliferation. Leuk Res (1982) 0.86

Gamma-ray-induced cell killing and chromosome abnormalities in the bone marrow of p53-deficient mice. Radiat Res (1996) 0.85

Effect of haemopoietic stem-cell proliferation regulators on early and late spleen colony-forming cells. Cell Tissue Kinet (1985) 0.85

Production of stem cell proliferation regulators by fractionated haemopoietic cell suspensions. Leuk Res (1979) 0.85

Macrophage inflammatory protein: its characteristics, biological properties and role in the regulation of haemopoiesis. Int J Hematol (1993) 0.84

BB-10010/MIP-1 alpha in vivo maintains haemopoietic recovery following repeated cycles of sublethal irradiation. Br J Cancer (1996) 0.84

Transgenerational effects of preconception paternal contamination with (55)Fe. Radiat Res (2001) 0.84

Apoptosis in bone marrow cells of mice with different p53 genotypes after gamma-rays irradiation in vitro. J Environ Pathol Toxicol Oncol (1995) 0.84

Spatial organisation of CFU-S proliferation regulators in the mouse femur. Leuk Res (1984) 0.84

Alpha-irradiation of haemopoietic tissue in pre- and postnatal mice: 2. Effects of mid-term contamination with 239Pu in utero. Int J Radiat Biol (1992) 0.84

Measurement of the duration of DNA synthesis in erythroid cells of the bone marrow using a double labelling autoradiographic technique designed specifically for use with haemopoietic tissues. Cell Tissue Kinet (1970) 0.84

Comparison of haemopoiesis in young and old mice. Mech Ageing Dev (1986) 0.83

Observations on the settling and recoverability of transplanted hemopoietic colony-forming units in the mouse spleen. Blood (1973) 0.83

The influence of thymus cells in hemopoiesis: stimulation of hemopoietic stem cells in a syngeneic, in vivo, situation. Blood (1973) 0.82

Effects of plutonium-239 on haemopoiesis. I. Quantitative and qualitative changes in CFU-S in different regions of the mouse femur and vertebrae. Int J Radiat Biol Relat Stud Phys Chem Med (1986) 0.82

Proliferation of spleen colony forming units (CFU-S8, CFU-S13) and cells with marrow repopulating ability. Stem Cells (1993) 0.82

Gamma irradiation of the fetus damages the developing hemopoietic microenvironment rather than the hemopoietic progenitor cells. Radiat Res (1995) 0.82

The relative spatial distribution of erythroid progenitor cells (BFUe and CFUe) in the normal mouse femur. Cell Tissue Kinet (1982) 0.81

Inhibitors of haemopoietic cell proliferation: reversibility of action. Br J Cancer (1974) 0.81

The effects of red blood cell extracts on the proliferation of erythrocyte precursor cells, in vivo. Cell Tissue Kinet (1977) 0.81

Kinetics of growth of haemopoietic colony cells in agar. Cell Tissue Kinet (1973) 0.81

Mechanisms of haemopoietic stem cell proliferation control. Blood Cells (1979) 0.80

A comparison of low and high dose-rate radiation for recipient mice in spleen-colony studies. Cell Tissue Kinet (1984) 0.80

Improved erythropoietic recovery in lethally irradiated rats after transfusion of buffy coat cells from the blood of partially shielded, heavily irradiated donors. Nature (1967) 0.79

Actions of the haemopoietic stem cell proliferation inhibitor. Biochem Pharmacol (1979) 0.79

Haemopoietic tissue. Baillieres Clin Haematol (1992) 0.79

Sources of haemopoietic stem cell proliferation: stimulators and inhibitors. Blood Cells (1980) 0.79

Hematopoietic stem cell regulation. II. Chronic effects of hypoxic-hypoxia on CFU kinetics. Blood (1973) 0.79

Clinical effects of human macrophage inflammatory protein-1 alpha MIP-1 alpha (LD78) administration to humans: a phase I study in cancer patients and normal healthy volunteers with the genetically engineered variant, BB-10010. Eur J Cancer (1998) 0.78

The kinetics of hematopoietic stem cells during and after hypoxia. A model analysis. Blut (1984) 0.78

Enrichment of CFU-S proliferation inhibitor-producing cells based on their identification by the monoclonal antibody F4/80. J Cell Sci (1985) 0.78

Hematopoietic stem cell regulation. I. Acute effects of hypoxic-hypoxia on CFU kinetics. Blood (1973) 0.78

Production of a multipotential cell (CFU-S) proliferation inhibitor by various populations of mouse and human macrophages. Br J Haematol (1988) 0.77

Characterisation of the differential response of normal and CML haemopoietic progenitor cells to macrophage inflammatory protein-1alpha. Leukemia (1999) 0.77

Feedback inhibitors in normal and tumor tissues. Int Rev Cytol (1996) 0.77

Controls on the cell cycle. Int J Radiat Biol Relat Stud Phys Chem Med (1986) 0.76

Haemopoietic stem cell proliferation: spatial and temporal considerations. Br J Cancer Suppl (1986) 0.76

Induction of lympho-haemopoietic malignancy: impact of preconception paternal irradiation. Int J Radiat Biol (1998) 0.76

A randomized phase-II study of BB-10010 (macrophage inflammatory protein- 1alpha) in patients with advanced breast cancer receiving 5-fluorouracil, adriamycin, and cyclophosphamide chemotherapy. Blood (1998) 0.76

Is hematopoiesis or its regulatory microenvironment the rate-limiting factor for LD50/30? Exp Hematol (1994) 0.75

Effect of specific growth inhibitors on fluorescein fluorescence polarization spectra in haemopoietic cells. Br J Cancer (1981) 0.75

The estrous cycle and the hemopoietic stem cell in the mouse. Blood (1972) 0.75

Long-term haemopoietic injury in mice after repeated irradiation: precursor-cell cycling and its regulation. Eur J Haematol (1988) 0.75

Regulators of stem cell proliferation in the haemopoietic tissues of W/Wv and S1/S1d mice. Leuk Res (1985) 0.75

Haemoglobin production in mice recovering from radiation. Nature (1969) 0.75

Induction of stem cell cycling in mice increases their sensitivity to a chemical leukaemogen: implications for inherited genomic instability and the bystander effect. Mutat Res (2002) 0.75

The murine haemopoietic stem cell: patterns of proliferation and differentiation. Adv Exp Med Biol (1982) 0.75

Erythropoietic cell proliferation during recovery from acute haemorrhage. Br J Haematol (1967) 0.75

The sensitivity of G0-state haemopoietic spleen colony-forming cells to a stimulus for proliferation. Cell Tissue Kinet (1986) 0.75

Spleen-colony cell kinetics. J Physiol (1968) 0.75

Alpha-particle irradiation of haemopoietic tissue in pre- and postnatal mice. 1: Distribution of plutonium-239 after mid-term contamination. Int J Radiat Biol (1991) 0.75

Kinetics of the recognizable erythrocyte precursor cells. Clin Haematol (1979) 0.75

Production of stem cell proliferation stimulators and inhibitors by haemopoietic cell suspensions. Biomedicine (1978) 0.75

Radiation and the plating efficiency of haemopoietic stem cells in the spleen colony assay technique. Br J Radiol (1971) 0.75

Lack of effect of a granulocyte proliferation inhibitor or their committed precursor cells. Biomedicine (1977) 0.75

The influence of thymus cells on the radiation dose-response of bone marrow stem cells. Br J Radiol (1973) 0.75

The relationship between CFU-S number and proliferation. Exp Hematol (1989) 0.75

The in vivo seeding of hemopoietic colony-forming cells in irradiated mice. Blood (1972) 0.75

The relationship of G0 to the cell cycle of haemopoietic spleen colony-forming cells. Cell Tissue Kinet (1981) 0.75

[Control of cell proliferation in haemopoietic tissue]. Haematologica (1974) 0.75

Modification of granulocytopoietic cell proliferation by granulocyte extracts. Boll Ist Sieroter Milan (1975) 0.75

Erythropoietin and the development of erythrocytes. Emergence of two erythroblast lines in erythropoiesis during growth and haemorrhage in the rat. Nature (1968) 0.75

Haemopoietic growth factors: their relevance in osteoclast formation and function. Ciba Found Symp (1988) 0.75

A feline model for the myelodysplastic syndrome: pre-leukaemic abnormalities caused in cats by infection with a new isolate of feline leukaemia virus (FeLV), AB/GM1. Haematologica (1988) 0.75